XtalPi lands massive $319M SoftBank-led round C to continue its high-tech drug discovery

It’s very much a race, so companies claiming to use AI to speed up the process have attracted major funding.

Though there have been no prominent breakthroughs to speak of resulting from the space, it’s hard to imagine any major player can afford to ignore it.

This company, founded in 2014, purports to offer extremely low-level simulation and prediction of target molecules, both simulating the physics at atomic levels and doing the more traditional data science work that eliminates dead ends and points towards more fruitful avenues for investigation.